Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

The design of attenuated vaccines for respiratory syncytial virus (RSV) historically focused on viruses made sensitive to physiologic temperature through point mutations in the genome. These prototype vaccines were not suitable for human infants primarily because of insufficient attenuation, genetic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Elliott, Matthew B., Pryharski, Karin S., Yu, Qingzhong, Parks, Christopher L., Laughlin, Todd S., Gupta, C. Kanta, Lerch, Robert A., Randolph, Valerie B., LaPierre, Natisha A., Heers Dack, Kristen M., Hancock, Gerald E.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Pathogenesis and Immunity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC415824/
https://ncbi.nlm.nih.gov/pubmed/15140975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.11.5773-5783.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars